Associated Papers
Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa.
Bhat V et al.
Thrombosis and Haemostasis, 2016
Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant.
von Drygalski A et al.
Journal of Thrombosis and Haemostasis : Jth, 2014
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C.
von Drygalski A et al.
Plos One, 2014
Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.
Cramer TJ et al.
Pathophysiology of Haemostasis and Thrombosis, 2010
Factor Va residues 311-325 represent an activated protein C binding region.
Yegneswaran S et al.
The Journal of Biological Chemistry, 2007
Partial glycosylation of Asn2181 in human factor V as a cause of molecular and functional heterogeneity. Modulation of glycosylation efficiency by mutagenesis of the consensus sequence for N-linked glycosylation.
Nicolaes GA et al.
Biochemistry, 1999
Select a paper to view details